drugset

drugset / Trial / NCT00658177

Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction

NCT00658177 ↗

Phase 3 Completed 463 enrolled Bayer GlaxoSmithKline · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to investigate the efficacy and safety of Vardenafil

Timeline

Start: 2003-06
Primary completion: —
Completion: 2004-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vardenafil	Small molecule	20 mg	—

Indications